A novel exon within the mdm2 gene modulates translation initiation in vitro and disrupts the p53-binding domain of mdm2 protein

Citation
N. Veldhoen et al., A novel exon within the mdm2 gene modulates translation initiation in vitro and disrupts the p53-binding domain of mdm2 protein, ONCOGENE, 18(50), 1999, pp. 7026-7033
Citations number
52
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ONCOGENE
ISSN journal
09509232 → ACNP
Volume
18
Issue
50
Year of publication
1999
Pages
7026 - 7033
Database
ISI
SICI code
0950-9232(19991125)18:50<7026:ANEWTM>2.0.ZU;2-H
Abstract
The mdm2 protein interacts with a number of proteins involved in cell growt h control. Such interactions favour cell proliferation and may explain the oncogenic potential of mdm2 when over-expressed in cells. Interaction with the tumour suppressor p53 involves the N-terminus of mdm2 and targets p53 f or rapid degradation by the ubiquitin pathway, We now describe a novel, hig hly conserved exon of mdm2 (exon alpha) which includes an in-frame UGA stop codon. Expression of exon alpha disrupts in vitro translation of the p53 b inding domain of mdm2. We propose that exon alpha induces translation re-in itiation at an internal AUG codon within the mdm2 alpha mRNA isoform. The p utative mdm2 alpha protein lacks the N-terminus of mdm2 and shows little, i f any, binding capacity for p53. Mdm2 alpha mRNA is expressed in a tissue-s pecific manner and is observed predominantly in testis and peripheral blood lymphocytes. We propose that mdm2 alpha expression may provide a mechanism for uncoupling mdm2-p53 interaction in certain cell types and/or under spe cific conditions of cell growth.